(Q44200341)

30 November 2017

0 references

Use of the polymerase chain reaction in the diagnosis of herpes simplex encephalitis: a decision analysis model (English)

1 reference

30 November 2017

1 reference

1 reference

1

1 reference

30 November 2017

Nease RF

2

1 reference

30 November 2017

Storch GA

series ordinal

3

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 October 1998

1 reference

American Journal of Medicine

30 November 2017

published in

1 reference

30 November 2017

volume

105

1 reference

30 November 2017

issue

4

1 reference

30 November 2017

page(s)

287-295

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900259-9

30 November 2017

1 reference

Vidarabine versus acyclovir therapy in herpes simplex encephalitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900259-9

Herpes simplex encephalitis: the brain biopsy controversy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900259-9

Rapid detection of herpes-simplex-virus DNA in cerebrospinal fluid of patients with herpes simplex encephalitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900259-9

Rapid diagnosis of herpes simplex encephalitis by nested polymerase chain reaction assay of cerebrospinal fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900259-9

Diagnosis of herpes encephalitis via Southern blotting of cerebrospinal fluid DNA amplified by polymerase chain reaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900259-9

Establishment of PCR for the early diagnosis of herpes simplex encephalitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900259-9

A prospective study of the polymerase chain reaction for detection of herpes simplex virus in cerebrospinal fluid submitted to the clinical virology laboratory

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900259-9

The diagnostic significance of the polymerase chain reaction and isoelectric focusing in herpes simplex virus encephalitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900259-9

Rapid diagnosis of herpes simplex virus encephalitis by using the polymerase chain reaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900259-9

Encephalitis in immunocompetent patients due to herpes simplex virus type 1 or 2 as determined by type-specific polymerase chain reaction and antibody assays of cerebrospinal fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900259-9

Significance and clinical relevance of the detection of herpes simplex virus DNA by the polymerase chain reaction in cerebrospinal fluid from patients with presumed encephalitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900259-9

A polymerase chain reaction assay of cerebrospinal fluid in patients with suspected herpes simplex encephalitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900259-9

Comparison of two hybridization assays for the rapid detection of PCR amplified HSV genome sequences from cerebrospinal fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900259-9

Mild herpes simplex encephalitis diagnosed by polymerase chain reaction: a case report and review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900259-9

Diagnosis of herpes simplex encephalitis: application of polymerase chain reaction to cerebrospinal fluid from brain-biopsied patients and correlation with disease. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900259-9

Use of brain biopsy for diagnostic evaluation of patients with suspected herpes simplex encephalitis: a statistical model and its clinical implications. NIAID Collaborative Antiviral Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900259-9

The clinical management of suspected herpes virus encephalitis. A decision-analytic view

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900259-9

The decision to biopsy, treat, or wait in suspected herpes encephalitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900259-9

Polymerase chain reaction for detection of herpes simplex virus encephalitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900259-9

Adenine arabinoside therapy of biopsy-proved herpes simplex encephalitis. National Institute of Allergy and Infectious Diseases collaborative antiviral study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900259-9

Amplification and characterization of herpesvirus DNA in cerebrospinal fluid from patients with acute encephalitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900259-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Detection of herpes simplex virus DNA from cerebrospinal fluid by PCR and a rapid, nonradioactive hybridization technique

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900259-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9343(98)00259-9

1 reference

30 November 2017

1 reference